FRM
BMY icon

Fox Run Management’s Bristol-Myers Squibb BMY Stock Holding History

Fox Run Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,032
Closed -$2.27M – 922
2025
Q4 		$2.27M Buy
42,032
+15,894
+61% +$765K 0.35% 20
2025
Q3 		$1.18M Buy
+26,138
New +$1.22M 0.18% 152
2025
Q1 		– Sell
-14,438
Closed -$817K – 928
2024
Q4 		$817K Buy
+14,438
New +$807K 0.15% 231
2024
Q3 		– Sell
-18,609
Closed -$773K – 816
2024
Q2 		$773K Buy
+18,609
New +$833K 0.15% 267
2023
Q3 		– Sell
-20,816
Closed -$1.33M – 717
2023
Q2 		$1.33M Buy
+20,816
New +$1.4M 0.37% 21
2023
Q1 		– Sell
-14,929
Closed -$1.07M – 671
2022
Q4 		$1.07M Buy
+14,929
New +$1.13M 0.43% 14
2022
Q1 		– Sell
-4,968
Closed -$310K – 506
2021
Q4 		$310K Sell
4,968
-13,048
-72% -$765K 0.18% 220
2021
Q3 		$1.07M Buy
18,016
+14,411
+400% +$949K 0.67% 4
2021
Q2 		$241K Buy
+3,605
New +$235K 0.22% 236
2019
Q4 		– Sell
-6,783
Closed -$344K – 392
2019
Q3 		$344K Buy
+6,783
New +$319K 0.31% 113
2019
Q1 		– Sell
-4,518
Closed -$235K – 476
2018
Q4 		$235K Sell
4,518
-5,409
-54% -$291K 0.12% 354
2018
Q3 		$616K Buy
9,927
+916
+10% +$54.4K 0.27% 106
2018
Q2 		$499K Sell
9,011
-10,721
-54% -$579K 0.16% 250
2018
Q1 		$1.25M Buy
+19,732
New +$1.27M 0.3% 38
2017
Q4 		– Sell
-16,700
Closed -$1.06M – 676
2017
Q3 		$1.06M Buy
+16,700
New +$975K 0.3% 48
2016
Q4 		– Sell
-6,500
Closed -$350K – 508
2016
Q3 		$350K Sell
6,500
-2,800
-30% -$180K 0.21% 200
2016
Q2 		$684K Buy
9,300
+3,600
+63% +$254K 0.33% 47
2016
Q1 		$364K Buy
+5,700
New +$359K 0.24% 161

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fox Run Management's BMY Position: Q1 2026 in Review

Fox Run Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 42,032 shares — an estimated $2.27M sold.

Fox Run Management first reported a position in BMY in Q1 2016 and held it in 18 quarters. The position peaked at $2.27M in Q4 2025. 2,532 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Fox Run Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Fox Run Management sold 42,032 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.27M.
  • Fox Run Management first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 18 quarters.
  • Fox Run Management's Bristol-Myers Squibb position peaked at $2.27M in Q4 2025.
  • 2,532 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.